On the public citation graph
Exploring the structural and molecular interaction landscape of nirmatrelvir and Mpro complex: The study might assist in designing more potent antivirals targeting SARS-CoV-2 and other viruses
0 signed · 84 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s00044-022-02951-6openalex-snapshot
The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations
inferredcites →https://doi.org/10.1007/s10822-010-9395-8openalex-snapshot
Computer-aided drug design platform using PyMOL
inferredcites →https://doi.org/10.1007/s11357-022-00631-2openalex-snapshot
A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs
inferredcites →https://doi.org/10.1007/s12033-022-00605-xopenalex-snapshot
Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets, and Structure-Based Druggability
inferredcites →https://doi.org/10.1007/s13238-021-00883-2openalex-snapshot
Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
inferredcites →https://doi.org/10.1016/j.antiviral.2023.105555openalex-snapshot
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses
inferredcites →https://doi.org/10.1016/j.biopha.2023.114367openalex-snapshot
Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
inferredcites →https://doi.org/10.1016/j.cell.2022.12.018openalex-snapshot
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
inferredcites →https://doi.org/10.1016/j.ijantimicag.2020.106055openalex-snapshot
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
inferredcites →https://doi.org/10.1016/j.ijbiomac.2022.07.254openalex-snapshot
Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein
inferredcites →https://doi.org/10.1016/j.jbc.2023.103004openalex-snapshot
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease
inferredcites →https://doi.org/10.1016/j.jiph.2022.11.024openalex-snapshot
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
inferredcites →https://doi.org/10.1016/j.omtn.2023.03.013openalex-snapshot
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
inferredcites →https://doi.org/10.1016/j.resconrec.2020.105169openalex-snapshot
A critical analysis of the impacts of COVID-19 on the global economy and ecosystems and opportunities for circular economy strategies
inferredcites →https://doi.org/10.1016/j.str.2020.10.007openalex-snapshot
Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
inferredcites →https://doi.org/10.1016/s1473-3099(22)00831-3openalex-snapshot
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
inferredcites →https://doi.org/10.1016/s1473-3099(23)00056-7openalex-snapshot
Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants
inferredcites →https://doi.org/10.1021/acs.accounts.2c00735openalex-snapshot
SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c01005openalex-snapshot
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
inferredcites →https://doi.org/10.1021/acscentsci.3c00538openalex-snapshot
Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir
inferredcites →https://doi.org/10.1021/bi036022qopenalex-snapshot
3C-like Proteinase from SARS Coronavirus Catalyzes Substrate Hydrolysis by a General Base Mechanism
inferredcites →https://doi.org/10.1021/ci200227uopenalex-snapshot
LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
inferredcites →https://doi.org/10.1038/d41586-022-03445-6openalex-snapshot
COVID ‘variant soup’ is making winter surges hard to predict
inferredcites →https://doi.org/10.1038/s41467-020-16954-7openalex-snapshot
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
inferredcites →https://doi.org/10.1038/s41467-022-29915-zopenalex-snapshot
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
inferredcites →https://doi.org/10.1038/s41586-023-06609-0openalex-snapshot
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir
inferredcites →https://doi.org/10.1038/s41591-022-02162-xopenalex-snapshot
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
inferredcites →https://doi.org/10.1038/s42003-022-03090-9openalex-snapshot
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
inferredcites →https://doi.org/10.1038/s42004-022-00758-5openalex-snapshot
A sustainable synthesis of the SARS-CoV-2 Mpro inhibitor nirmatrelvir, the active ingredient in Paxlovid
inferredcites →https://doi.org/10.1056/nejmoa2118542openalex-snapshot
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
inferredcites →https://doi.org/10.1056/nejmoa2204919openalex-snapshot
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
inferredcites →https://doi.org/10.1080/14756366.2021.1954919openalex-snapshot
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
inferredcites →https://doi.org/10.1093/bioinformatics/btr497openalex-snapshot
iMod: multipurpose normal mode analysis in internal coordinates
inferredcites →https://doi.org/10.1093/nar/gkab294openalex-snapshot
PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA
inferredcites →https://doi.org/10.1093/nar/gkab543openalex-snapshot
CROssBAR: comprehensive resource of biomedical relations with knowledge graph representations
inferredcites →https://doi.org/10.1093/nar/gkac323openalex-snapshot
GRaSP-web: a machine learning strategy to predict binding sites based on residue neighborhood graphs
inferredcites →https://doi.org/10.1093/nar/gkac365openalex-snapshot
RING 3.0: fast generation of probabilistic residue interaction networks from structural ensembles
inferredcites →https://doi.org/10.1093/nar/gku339openalex-snapshot
iMODS: internal coordinates normal mode analysis server
inferredcites →https://doi.org/10.1093/nar/gkw419openalex-snapshot
Heatmapper: web-enabled heat mapping for all
inferredcites →https://doi.org/10.1093/nar/gky309openalex-snapshot
MOLEonline: a web-based tool for analyzing channels, tunnels and pores (2018 update)
inferredcites →https://doi.org/10.1093/nar/gky473openalex-snapshot
CASTp 3.0: computed atlas of surface topography of proteins
inferredcites →https://doi.org/10.1093/protein/8.2.127openalex-snapshot
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
inferredcites →https://doi.org/10.1126/sciadv.add7197openalex-snapshot
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
inferredcites →https://doi.org/10.1126/science.abl4784openalex-snapshot
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
inferredcites →https://doi.org/10.1155/2022/7341493openalex-snapshot
Paxlovid: Mechanism of Action, Synthesis, and In Silico Study
inferredcites →https://doi.org/10.1186/s40001-021-00626-3openalex-snapshot
Potential therapeutic options for COVID-19: an update on current evidence
inferredcites →https://doi.org/10.1371/journal.ppat.1011592openalex-snapshot
A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations
inferredcites →https://doi.org/10.15585/mmwr.mm7205e1openalex-snapshot
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January…
inferredcites →https://doi.org/10.26355/eurrev_202004_20871openalex-snapshot
SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options.
inferredcites →https://doi.org/10.3389/fchem.2021.622898openalex-snapshot
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
inferredcites →https://doi.org/10.3389/fphar.2020.01258openalex-snapshot
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
inferredcites →https://doi.org/10.3389/fphar.2021.704205openalex-snapshot
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
inferredcites →https://doi.org/10.3390/biom11040607openalex-snapshot
SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
inferredcites →https://doi.org/10.3390/ijms24032264openalex-snapshot
Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge
inferredcites →https://doi.org/10.3390/molecules27082523openalex-snapshot
Advances in the Development of SARS-CoV-2 Mpro Inhibitors
inferredcites →https://doi.org/10.3390/v15010167openalex-snapshot
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
inferredcites →https://doi.org/10.34172/ijhpm.2022.7212openalex-snapshot
Ensuring Global Health Equity in a Post-pandemic Economy
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/inmd.20240074openalex-snapshot
The relationship between selenium and viral diseases
inferred← citeshttps://doi.org/10.1002/rmv.2526openalex-snapshot
Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive review
inferred← citeshttps://doi.org/10.1007/s42452-025-07657-zopenalex-snapshot
An ensemble learning approach for detecting bacterial infections using chest X-ray imaging
inferred← citeshttps://doi.org/10.1016/j.bios.2026.118848openalex-snapshot
Differential kinetics of SARS-CoV-2 proteases revealed by a two-color, BRET-based dual protease biosensor, DuProSense
inferred← citeshttps://doi.org/10.1016/j.csbr.2024.100029openalex-snapshot
Unveiling novel hyperglycosylated analog of human erythropoietin: A comprehensive computational exploration
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2024.116644openalex-snapshot
Design of immunoassay based biosensor platforms for SARS-CoV-2 detection using highly specific monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2024.116670openalex-snapshot
Blueprint of a pandemic: Insights from SARS-CoV-2 genomics surveillance in Meghalaya, India
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2025.116996openalex-snapshot
“Enhanced seropositivity and sustained antibody response among healthcare workers: A seroprevalence study during the SARS-CoV-2 pandemic
inferred← citeshttps://doi.org/10.1016/j.genrep.2025.102196openalex-snapshot
Evaluation of the gene expression of CD27 and CD73, and the anti-SARS-CoV-2 Spike IgG level before and after receiving the inactivated SARS-COV-2 vaccine
inferred← citeshttps://doi.org/10.1016/j.jcvp.2025.100208openalex-snapshot
Persistent nucleic acids from endemic human coronaviruses in adenoids: Do they enhance children's immune response to SARS-CoV-2 infection?
inferred← citeshttps://doi.org/10.1016/j.medmic.2025.100124openalex-snapshot
Evaluating gene expression patterns for NF-κB1, TNF, and VEGF A& VEGF B in a mouse model of SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/j.micinf.2024.105381openalex-snapshot
The PDZ domain of the E protein in SARS-CoV induces carcinogenesis and poor prognosis in LUAD
inferred← citeshttps://doi.org/10.1016/j.micpath.2025.107687openalex-snapshot
Advances in COVID-19 Therapeutics: Exploring the role of lectins and protease inhibitors
inferred← citeshttps://doi.org/10.1016/j.molstruc.2024.140707openalex-snapshot
Synthesis, characterization, proteolytic activity inhibition, ADMET prediction, and molecular docking studies of novel indole derivatives as potential SARS-CoV-2 protease inhibitors
inferred← citeshttps://doi.org/10.1096/fj.202403197ropenalex-snapshot
ELV ‐ N34 , RvD6 ‐Isomer, or NPD1 Halt Replication of SARS ‐ CoV ‐2 Omicron BA.5 Virus in Human Lung and Nasal Cells
inferred← citeshttps://doi.org/10.1097/js9.0000000000004053openalex-snapshot
The impact of COVID-19 on the treatment and prognosis of cancer patients
inferred← citeshttps://doi.org/10.1111/bph.70377openalex-snapshot
Targeting protein–protein interactions with reversible covalent modalities: Non‐cysteine chemistries
inferred← citeshttps://doi.org/10.1128/mbio.01088-24openalex-snapshot
The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2
inferred← citeshttps://doi.org/10.1371/journal.pone.0334662openalex-snapshot
Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches
inferred← citeshttps://doi.org/10.1515/tnsci-2022-0360openalex-snapshot
Identifying key biomarkers and therapeutic candidates for post-COVID-19 depression through integrated omics and bioinformatics approaches
inferred← citeshttps://doi.org/10.2174/0115665240361878250601074746openalex-snapshot
Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration
inferred← citeshttps://doi.org/10.2174/0118756298349125250306033716openalex-snapshot
Peptidomimetics as Emerging Inhibitor Against Mpro of SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/ph17020240openalex-snapshot
Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning
inferred← citeshttps://doi.org/10.3390/ph18081144openalex-snapshot
Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target
inferred← citeshttps://doi.org/10.37349/emed.2025.1001331openalex-snapshot
Analysis of COVID-19 prevalence in Belarus, Thailand, and Lithuania utilizing the SIR model during the COVID era
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.